News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter-04-01-2020
Volume15
Issue 4
Pages: 12

trinamiX Launches a Mobile NIR Spectroscopy Solution

The measurement device comes with an infrared semiconductor to examine the molecular structure of materials in a wavelength range up to 2,5 µm for factory and lab applications.

trinamiX GmbH, a subsidiary of BASF SE, announced on March 23, 2020 that it is launching a mobile, handheld near-infrared (NIR) spectroscopy solution for factory and laboratory applications.

The measurement device comes equipped with an infrared semiconductor to efficiently examine the molecular structure of materials in a wavelength range up to 2,5 µm, along with mobile and robust hardware, precise data and material analytics, and molecular and chemical capabilities.

Device capabilities include inbound control, quality checks, on-the-field analytics, and material sorting and identification. The company states that trinamiX production capabilities are suited for high-volume production that runs all the way up to consumer electronics-level supply demands.

Source: trinamiX

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content